Armenia vs Saudi Arabia: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Armenia
- Saudi Arabia
How they compare
Armenia currently reports 267.92 deaths against 247.11 deaths in Saudi Arabia, a difference of 20.81 deaths.
That makes Armenia's figure about 1.1 times Saudi Arabia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Saudi Arabia ahead.
Armenia ranks 105th and Saudi Arabia ranks 107th of 157 countries.
Across the 4 decades both report, Armenia averaged higher in 1 and Saudi Arabia in 3.
Head to head by decade
| Decade | Armenia | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 56.24 deaths | 56.24 deaths | Saudi Arabia |
| 2000s | 7.12 deaths | 210.83 deaths | 203.71 deaths | Saudi Arabia |
| 2010s | 94.52 deaths | 142.31 deaths | 47.8 deaths | Saudi Arabia |
| 2020s | 226.81 deaths | 221.23 deaths | 5.58 deaths | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Armenia or Saudi Arabia?
- Armenia, at 267.92 deaths against 247.11 deaths in Saudi Arabia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Armenia and Saudi Arabia?
- 20.81 deaths, with Armenia ahead.
- How many years of comparable data are there for Armenia and Saudi Arabia?
- 35 years are reported by both, from 1990 to 2024.
- How do Armenia and Saudi Arabia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Armenia ranks 105th and Saudi Arabia ranks 107th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.